MDL-12330A potentiates TRAIL-induced apoptosis in gastric cancer cells through CHOP-mediated DR5 upregulation

MDL-12330A is a widely used adenylyl cyclase (AC) inhibitor that blocks AC/cAMP signaling. In this study, we demonstrated a novel antitumor activity of this drug in gastric carcinoma (GC) cell lines. In these GC cells, MDL-12330A reduced cell viability and induced cell death in a concentration-depen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sung-Chul, Han, Song Iy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507778/
https://www.ncbi.nlm.nih.gov/pubmed/28706453
http://dx.doi.org/10.4196/kjpp.2017.21.4.397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507778/
https://www.ncbi.nlm.nih.gov/pubmed/28706453
http://dx.doi.org/10.4196/kjpp.2017.21.4.397

Ejemplares similares